Showing results (1-10 of 40) with videos related to
Sort By:
Pageof 4
Cerebral Cortex (New York, N.Y. : 1991)|December 5, 2019
Sex-specific Difference of Hippocampal Synaptic Plasticity in Response to Sex NeurosteroidsNicola Brandt, Ricardo Vierk, Lars Fester, et al.Pathology International|April 22, 2020
Upregulation of PTTG1 is associated with poor prognosis in prostate cancerChristoph Fraune, Serhiy Yehorov, Andreas M Luebke, et al.Pathology, Research and Practice|July 25, 2022
Large-scale human tissue analysis identifies Uroplakin 1a as a putative diagnostic marker for urothelial cancerViktor Reiswich, Steffi Könemann, Maximilian Lennartz, et al.Journal of Extracellular Biology|February 23, 2026
Extracellular Vesicle Properties and Functions Are Defined by the Originating Cell's Fitness StatusStephanie Leyk, Imke Liebold, Clarissa Lanzloth, et al.Pathology|April 23, 2020
High CHK2 protein expression is a strong and independent prognostic feature in ERG negative prostate cancerTill Eichenauer, Felix Federlein, Katharina Möller, et al.Human Pathology|May 13, 2022
Large-scale human tissue analysis identifies Uroplakin 1b as a putative diagnostic marker in surgical pathologyViktor Reiswich, Gonca Akdeniz, Maximilian Lennartz, et al.Virchows Archiv : an International Journal of Pathology|October 8, 2024
TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entitiesKatharina Möller, Tayyaba Gulzar, Maximilian Lennartz, et al.Disease Markers|January 25, 2020
Prevalence of Syndecan-1 (CD138) Expression in Different Kinds of Human Tumors and Normal TissuesSimon Kind, Christina Merenkow, Franziska Büscheck, et al.Annals of Diagnostic Pathology|August 27, 2022
Cytokeratin 10 (CK10) expression in cancer: A tissue microarray study on 11,021 tumorsRia Uhlig, Moussa Abboud, Natalia Gorbokon, et al.Expert Review of Molecular Diagnostics|July 22, 2022
Villin expression in human tumors: a tissue microarray study on 14,398 tumorsDavid Dum, Maximilian Lennartz, Anne Menz, et al.Pageof 4